As of 2025-09-19, the Relative Valuation of Cytokinetics Inc (CYTK) is (128.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 49.29 USD, the upside of Cytokinetics Inc based on Relative Valuation is -360.3%.
The range of the Relative Valuation is (124.14) - (124.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.4x - 24.5x | 23.4x |
| Forward P/E multiples | 24.5x - 29.9x | 27.2x |
| Fair Price | (124.14) - (124.14) | (128.32) |
| Upside | -351.9% - -351.9% | -360.3% |
| Date | P/E |
| 2025-09-16 | -9.82 |
| 2025-09-15 | -9.76 |
| 2025-09-12 | -10.09 |
| 2025-09-11 | -10.52 |
| 2025-09-10 | -10.26 |
| 2025-09-09 | -10.16 |
| 2025-09-08 | -10.28 |
| 2025-09-05 | -10.46 |
| 2025-09-04 | -9.82 |
| 2025-09-03 | -9.87 |
| 2025-09-02 | -9.79 |
| 2025-08-29 | -6.97 |
| 2025-08-28 | -7.37 |
| 2025-08-27 | -7.47 |
| 2025-08-26 | -7.54 |
| 2025-08-25 | -7.30 |
| 2025-08-22 | -7.57 |
| 2025-08-21 | -7.51 |
| 2025-08-20 | -7.37 |
| 2025-08-19 | -7.47 |
| 2025-08-18 | -7.69 |
| 2025-08-15 | -7.63 |
| 2025-08-14 | -7.64 |
| 2025-08-13 | -7.28 |
| 2025-08-12 | -6.77 |
| 2025-08-11 | -6.56 |
| 2025-08-08 | -6.73 |
| 2025-08-07 | -6.96 |
| 2025-08-06 | -6.94 |
| 2025-08-05 | -7.14 |
| 2025-08-04 | -7.22 |
| 2025-08-01 | -7.24 |
| 2025-07-31 | -7.43 |
| 2025-07-30 | -7.14 |
| 2025-07-29 | -7.09 |
| 2025-07-28 | -7.23 |
| 2025-07-25 | -7.34 |
| 2025-07-24 | -7.36 |
| 2025-07-23 | -7.49 |
| 2025-07-22 | -7.44 |
| 2025-07-21 | -7.29 |
| 2025-07-18 | -7.35 |
| 2025-07-17 | -7.68 |
| 2025-07-16 | -7.63 |
| 2025-07-15 | -7.50 |
| 2025-07-14 | -7.61 |
| 2025-07-11 | -7.30 |
| 2025-07-10 | -7.22 |
| 2025-07-09 | -7.23 |
| 2025-07-08 | -6.76 |